Multidrug resistance protein 1/P-glycoprotein (MRP1/P-gp), the archetypal representative of this family, is actively involved in BC cancer refractoriness to a variety of compounds, including anthracyclines, platinum agents, and taxanes [110]. The gene discussed is PGP; the disease is breast cancer.